Aequus Pharmaceuticals Inc (AQSZF) Stock Price & News

All values in CAD	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	221.95K	226.54K	218.22K	251.75K
Cost of goods sold	74.90K	90.09K	110.75K	119.68K
Cost of revenue	74.90K	90.09K	110.75K	119.68K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	454.05K	224.01K	199.28K	219.75K
Operating expense	454.05K	224.01K	199.28K	219.75K
Total operating expenses	528.95K	314.09K	310.03K	339.43K
Operating income	-307.00K	-87.55K	-91.81K	-87.68K
Other non operating income	-43.06K	-	-	-
EBT including unusual items	-217.81K	-645.10K	-163.91K	370.48K
EBT excluding unusual items	-421.46K	-159.90K	-163.91K	-147.62K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-217.81K	-645.10K	-163.91K	370.48K
Net profit margin	-98.14%	-284.76%	-75.11%	147.16%
Earnings per share	-	-	-	-
Interest and investment income	2.54K	-	-	-
Interest expense	-71.99K	-69.97K	-70.30K	-58.93K
Net interest expenses	-69.45K	-69.97K	-70.30K	-58.93K
Depreciation and amortization charges	-	-	-	-
EBITDA	-305.55K	-	-	-
Gain or loss from assets sale	-	-	-	-

Ask anything